Mossler Mark (CIK 0001992219)

Latest company ownership

CCCC - C4 Therapeutics, Inc.
Role: Chief Accounting Officer
Shares held
18,204
Last filed at
Feb 18, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 14, 2025 Feb 18, 2025 C4 Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -1,586 -8.01% ✗ $5K